Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov-Dec;15(6):102268.
doi: 10.1016/j.dsx.2021.102268. Epub 2021 Sep 4.

Diabetes Mellitus and COVID-19: Review Article

Mahmoud Nassar  1 , Ahmed Daoud  2 , Nso Nso  3 , Luis Medina  4 , Victoria Ghernautan  5 , Harangad Bhangoo  6 , Andrew Nyein  7 , Mahmoud Mohamed  8 , Ahmed Alqassieh  9 , Karim Soliman  10 , Mostafa Alfishawy  11 , Issac Sachmechi  12 , Anoop Misra  13
Affiliations
Review

Diabetes Mellitus and COVID-19: Review Article

Mahmoud Nassar et al. Diabetes Metab Syndr. 2021 Nov-Dec.

Abstract

Background and aims: We aim to cover most of the current evidence on the mutual effect of diabetes & COVID-19 infection on each other and the management of the COVID-19 patients with diabetes.

Methods: We utilized databases to review the current evidence related to diabetes mellitus and COVID-19.

Results: We discussed the most recent evidence of diabetes milieus and COVID-19 regarding risk factors, management, complications, and telemedicine.

Conclusion: Diabetes mellitus is associated with a significant risk of complications, extended hospital stays, and mortality in COVID-19 infected patients.

Keywords: COVID-19; Diabetes mellitus; Management; Pathophysiology; Risk factor; Typ 2; Type 1.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors confirm the absence of personal and financial interests impacting the outcomes of this research study.

Figures

Fig. 1
Fig. 1
Pathophysiology of diabetes mellitus and COVID-19.
See this image and copyright information in PMC

References

    1. Elamari S., et al. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. The Pan African medical journal. 2020;37 32-32. - PMC - PubMed
    1. Ceriello A. Hyperglycemia and COVID-19: what was known and what is really new? Diabetes Res Clin Pract. 2020;167 108383-108383. - PMC - PubMed
    1. Nassar M., et al. Diabetes & metabolic syndrome. Clinical Research & Reviews; 2021. COVID-19 vaccine-induced myocarditis case report with literature review; p. 102205. - PMC - PubMed
    1. Sterne J.A.C., et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. Jama. 2020;324(13):1330–1341. - PMC - PubMed
    1. Alessi J., et al. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes. Diabetol Metab Syndrome. 2020;12:80. - PMC - PubMed